The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK

The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK

Susan C Edwards,1 Sian E Fairbrother,2 Anna Scowcroft,3 Gavin Chiu,4 Andrew Ternouth,3 Brian J Lipworth5 1Department of Market Access Pricing & Outcomes Research, 2Department of Medical Affairs - Respiratory, 3Department of Market Access, 4Department of Prescription Medicine - Respi...

Full description

Bibliographic Details
Main Authors:	Edwards SC, Fairbrother SE, Scowcroft A, Chiu G, Ternouth A, Lipworth BJ
Format:	Article
Language:	English
Published:	Dove Medical Press 2016-11-01
Series:	International Journal of COPD
Subjects:	COPD UK primary care setting bronchodilators prescribing patterns monotherapy
Online Access:	https://www.dovepress.com/the-burden-of-chronic-obstructive-pulmonary-disease-associated-with-ma-peer-reviewed-article-COPD

Similar Items

Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO® and OTEMTO® studies: a subgroup analysis by age
by: Ferguson GT, et al.
Published: (2016-10-01)

Stable Clinical Course of Chronic Obstructive Pulmonary Disease Patients in the Era of Double Bronchodilator Therapy: A Single Referral Center Experience
by: Sun Hye Shin, et al.
Published: (2020-08-01)

Patient-Reported Burden of Illness in a Prevalent COPD Population Treated with Long-Acting Muscarinic Antagonist Monotherapy: A Claims-Linked Patient Survey Study
by: Beth Hahn, et al.
Published: (2019-04-01)

Double bronchodilation in chronic obstructive pulmonary disease: a crude analysis from a systematic review
by: Lopez-Campos JL, et al.
Published: (2017-06-01)

The adjusted impact of different severities of acute exacerbations and medications on the risk of developing dementia in COPD patients
by: Kuo-Hua Chia, et al.
Published: (2023-03-01)

The efficacy and safety of combined tiotropium and olodaterol via the Respimat® inhaler in patients with COPD: results from the Japanese sub-population of the Tonado® studies
by: Ichinose M, et al.
Published: (2016-08-01)

When is dual bronchodilation indicated in COPD?
by: Thomas M, et al.
Published: (2017-08-01)

Pulmonologists’ Opinion on the Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Patients in Spain: A Cross-Sectional Survey
by: Miravitlles M, et al.
Published: (2022-07-01)

Differential Response to 12 Weeks of Once-Daily Tiotropium/Olodaterol Fixed Dose Combination in Patients with COPD: A Multidimensional Response Profiling in the TORRACTO Study
by: Posthuma R, et al.
Published: (2023-06-01)

Pre- and post-bronchodilator lung function as predictors of mortality in the Lung Health Study
by: Diaz-Guzman Enrique, et al.
Published: (2011-10-01)

Pharmacological Treatment in Asthma and COPD
by: Tomoaki Hoshino, et al.
Published: (2009-01-01)

CHOICE OF ALTERNATIVE MONOTHERAPY IN EPILEPSY
by: I. Ju. Kovaleva
Published: (2016-05-01)

Influence of Mechanical Ventilation Modes on the Efficacy of Nebulized Bronchodilators in the Treatment of Intubated Adult Patients with Obstructive Pulmonary Disease
by: Cibelle Andrade Lima, et al.
Published: (2023-05-01)

Global initiative gold and national recommendations on the management of patients with chronic obstructive pulmonary disease (COPD): the place of double bronchodilation
by: A. A. Vizel, et al.
Published: (2019-12-01)

Effect of timing of bronchodilator therapy initiation on exacerbations in patients with chronic obstructive pulmonary disease: a retrospective cohort study
by: Hideyasu Yamada, et al.
Published: (2022-09-01)

A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classifications
by: Ding B, et al.
Published: (2017-05-01)

Pharmacoeconomic analysis of the use of a fixed combination of tiotropium bromide and olodaterol as maintenance therapy in patients with chronic obstructive pulmonary disease in the Russian Federation
by: S. К. Zyryanov, et al.
Published: (2022-07-01)

Clinical outcomes of long-term inhaled combination therapies in patients with bronchiectasis and airflow obstruction
by: Hyo Jin Lee, et al.
Published: (2024-01-01)

The Role of Dual Bronchodilation and the Conscientious Use of Inhaled Corticosteroid in COPD
by: Ricardo G. Figueiredo, et al.
Published: (2022-08-01)

LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
by: Marc Miravitlles, et al.
Published: (2022-11-01)

Prevention of copd exacerbations. Focus on dual bronchodilators
by: V. V. Arkhipov
Published: (2018-10-01)

12-Hour fixed-dose combination of andrenergic agonist and cholinergic antagonist in a new administration device: analytical review
by: A. A. Vizel, et al.
Published: (2018-10-01)

Study on factors associated with post bronchodilator reversibility among patients presenting with dyspnea: An experience at a tertiary care academic hospital in Kerala
by: Asmita A Mehta, et al.
Published: (2022-01-01)

The Importance of Inhaler Adherence to Prevent COPD Exacerbations
by: Jose R. Jardim, et al.
Published: (2019-04-01)

Comparison of Effectiveness Using Different Dual Bronchodilator Agents in Chronic Obstructive Pulmonary Disease Treatment
by: Shih-Lung Cheng
Published: (2021-06-01)

ACO (Asthma–COPD Overlap) Is Independent from COPD: The Case Against
by: Peter M. A. Calverley, et al.
Published: (2021-06-01)

The future of inhalation therapy in chronic obstructive pulmonary disease
by: Mario Cazzola, et al.
Published: (2022-01-01)

Extracorporeal shock wave lithotripsy as monotherapy for vesical calculi
by: Arjun Nagaraj, et al.
Published: (2024-01-01)

Driving performance of patients with epilepsy undergoing antiepileptic monotherapy
by: Kunihiro Iwamoto, et al.
Published: (2023-03-01)

Optimization of Long-Acting Bronchodilator Dose Ratios Using Isolated Guinea Pig Tracheal Rings for Synergistic Combination Therapy in Asthma and COPD
by: Elena Menchi, et al.
Published: (2022-08-01)

Predictors of Single Bronchodilation Treatment Response for COPD: An Observational Study with the Trace Database Cohort
by: Laura Carrasco Hernández, et al.
Published: (2021-04-01)

The prevalence of bronchodilator responsiveness of the small airway (using mid-maximal expiratory flow) in COPD - a retrospective study
by: Nowaf Y. Alobaidi, et al.
Published: (2022-12-01)

Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD
by: Yamauchi Y, et al.
Published: (2016-06-01)

General practitioners’ adherence to the COPD GOLD guidelines: baseline data from the Swiss COPD Cohort Study
by: S Schafroth
Published: (2010-04-01)

General practitioners’ adherence to the COPD GOLD guidelines: baseline data from the Swiss COPD Cohort Study
by: A Jochmann, et al.
Published: (2010-08-01)

Impact of adherence to GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in a Swiss COPD cohort
by: Anja Jochmann, et al.
Published: (2012-03-01)

Efficacy of Levetiracetam Monotherapy in Childhood Epilepsy
by: Müjgan ARSLAN, et al.
Published: (2017-04-01)

Characteristics of Patients with Chronic Obstructive Pulmonary Disease Treated with Long-Acting Bronchodilators in a Real-World Setting in Singapore: A Single-Center Observational Study
by: Sim M, et al.
Published: (2022-06-01)

Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trial
by: F. Maltais, et al.
Published: (2020-10-01)

Monotherapy treatment with chlorthalidone or amlodipine in the systolic blood pressure intervention trial (SPRINT)
by: Deep Vakil, et al.
Published: (2021-07-01)